3 results on '"Whatley, Eleni M."'
Number of results to display per page
Search Results
2. Standardized Data Elements for Patients With Acute Pulmonary Embolism: A Consensus Report from the Pulmonary Embolism Research Collaborative
- Author
-
Rosenfield, Kenneth, Bowers, Terry R., Barnett, Christopher F., Davis, George A., Giri, Jay, Horowitz, James M., Huisman, Menno V., Hunt, Beverley J., Keeling, Brent, Kline, Jeffrey A., Klok, Frederikus A., Konstantinides, Stavros V., Lanno, Michelle T., Lookstein, Robert, Moriarty, John M., Ní Áinle, Fionnuala, Reed, Jamie L., Rosovsky, Rachel P., Royce, Sara M., Secemsky, Eric A., Sharp, Andrew S. P., Sista, Akhilesh K., Smith, Roy E., Wells, Phil, Yang, Joanna, Whatley, Eleni M., Abudi, Tami, Adams, George, Ahmad, Hajira, Ajao, Adebola, Archard, Erin, Auger, William, Avila-Tang, Erika, Barnes, Geoff, Barnett, Christopher, Bashir, Riyaz, Benenati, James, Berman, Aaron, Bowers, Terry, Buck, Michael, Burnett, Allison, Cameron, Scott, Cavanaugh, Kenneth, Cerminaro, Michael, Daniel, Daniel, Daves, Seanna, Davis, George, Dicks, Andrew, Elder, Mahir, Farrell, Ann, Garman, Alissa, Gatzemeier, Jamee, Giannikopoulos, Demetri, Gibson, Michael, Goldberg, Joshua, Gonsalves, Carin, Grodzin, Charles, Gundert, Emily, Gurley, John, Heresi, Gustavo, Hlozek, Kristen, Hoerst, Stephen, Hooks, Brandon, Horowitz, James, Jaber, Wissam, Jaff, Michael, Jimenez, David, Johnston-Cox, Hillary, Kaatz, Scott, Kolluri, Raghu, Laird, John, Lake, Leslie, Langston, Matthew, Lossef, Steven, Love, Charles, Mackel, Julie, Massaro, Lori, McDaniel, Michael, McNally, Vicki, Merli, Geno, Mina, Bushra, Monreal, Manuel, Moores, Lisa, Morris, Timothy, Nossair, Fadi, O’Connell, Gregory, O’Corragain, Oisin, Ouriel, Kenneth, Parikh, Sahil, Piazza, Gregory, Pohlson, Katie, Polverini, Peter, Pomeroy, Jordan, Pugliese, Steve, Pullin, Brian, Quinto, Brian, Rali, Parth, Rivera-Lebron, Belinda, Robertson, Bill, Rosengard, Bruce, Shaw, Miranda, Simonton, Chuck, Sista, Akhilesh, Smith, Roy, Spyropoulos, Alex, Srivastava, Sanjay, Sterling, Keith, Strauss, Jayme, Taber, Margaret, Tapson, Victor, Tawney, Adam, Tu, Thomas, Valent, Tom, Venkat, Venkat, Walach, Elad, Ward, Rebecca, Ward, Adam, Weinberg, Ido, Wells, Phil, West, Frances Mae, West, Nick, Whatley, Eleni, Yang, Joanna, and Yongpravat, Charlie
- Abstract
Recent advances in therapy and the promulgation of multidisciplinary pulmonary embolism teams show great promise to improve management and outcomes of acute pulmonary embolism (PE). However, the absence of randomized evidence and lack of consensus leads to tremendous variations in treatment and compromises the wide implementation of new innovations. Moreover, the changing landscape of health care, where quality, cost, and accountability are increasingly relevant, dictates that a broad spectrum of outcomes of care must be routinely monitored to fully capture the impact of modern PE treatment. We set out to standardize data collection in patients with PE undergoing evaluation and treatment, and thus establish the foundation for an expanding evidence base that will address gaps in evidence and inform future care for acute PE. To do so, >100 international PE thought leaders convened in Washington, DC, in April 2022 to form the Pulmonary Embolism Research Collaborative. Participants included physician experts, key members of the US Food and Drug Administration, patient representatives, and industry leaders. Recognizing the multidisciplinary nature of PE care, the Pulmonary Embolism Research Collaborative was created with representative experts from stakeholder medical subspecialties, including cardiology, pulmonology, vascular medicine, critical care, hematology, cardiac surgery, emergency medicine, hospital medicine, and pharmacology. A list of critical evidence gaps was composed with a matching comprehensive set of standardized data elements; these data points will provide a foundation for productive research, knowledge enhancement, and advancement of clinical care within the field of acute PE, and contribute to answering urgent unmet needs in PE management. Evidence produced through the Pulmonary Embolism Research Collaborative, as it is applied to data collection, promises to provide crucial knowledge that will ultimately produce a robust evidence base that will lead to standardization and harmonization of PE management and improved outcomes.
- Published
- 2024
- Full Text
- View/download PDF
3. Postmarketing Surveillance of Inferior Vena Cava Filters Among US Medicare Beneficiaries: The SAFE-IVC Study.
- Author
-
Ferro EG, Mackel JB, Kramer RD, Torguson R, Whatley EM, O'Connell G, Pullin B, Watson NW, Li S, Song Y, Krawisz AK, Carroll BJ, Schermerhorn ML, Weinstein JL, Farb A, Zuckerman B, Yeh RW, and Secemsky EA
- Abstract
Importance: Inferior vena cava filters (IVCFs) are commonly used to prevent pulmonary embolism in selected clinical scenarios, despite limited evidence to support their use. Current recommendations from professional societies and the US Food and Drug Administration endorse timely IVCF retrieval when clinically feasible. Current IVCF treatment patterns and outcomes remain poorly described., Objectives: To evaluate temporal trends and practice patterns in IVCF insertion and retrieval among older US patients and report the incidence of periprocedural and long-term safety events of indwelling and retrieved IVCFs., Design, Setting, and Participants: Prespecified, retrospective, observational cohort of Medicare Fee-for-Service (FFS) beneficiaries, leveraging 100% of samples of inpatient and outpatient claims data from January 1, 2013, to December 31, 2021., Exposure: First-time IVCF insertion while insured by Medicare FFS., Main Outcomes and Measures: The primary safety outcome was the composite of all-cause death, filter-related complications (eg, fracture, embolization), operating room visits following filter-related procedures, or new diagnosis of deep vein thrombosis (DVT). Events were considered periprocedural if they occurred within 30 days of IVCF insertion or retrieval and long-term if they occurred more than 30 days after., Results: Among 270 866 patients with IVCFs placed during the study period (mean age, 75.1 years; 52.8% female), 64.9% were inserted for first-time venous thromboembolism (VTE), 26.3% for recurrent VTE, and 8.8% for VTE prophylaxis. Of these patients, 63.3% had major bleeds or trauma within 30 days of IVCF insertion. The volume of insertions decreased from 44 680 per year in 2013 to 19 501 per year in 2021. The cumulative incidence of retrieval was 15.3% at a median of 1.2 years and 16.8% at maximum follow-up of 9.0 years. Older age, more comorbidities, and Black race were associated with a decreased likelihood of retrieval, whereas placement at a large teaching hospital was associated with an increased likelihood of retrieval. The incidence of caval thrombosis and DVT among patients with nonretrieved IVCFs was 2.2% (95% CI, 2.1%-2.3%) and 9.2% (95% CI, 9.0%-9.3%), respectively. The majority (93.5%) of retrieval attempts were successful, with low incidence of 30-day complications (mortality, 0.7% [95% CI, 0.6%-0.8%]; filter-related complications, 1.4% [95% CI, 1.2%-1.5%])., Conclusions and Relevance: In this large, US real-world analysis, IVCF insertion declined, yet retrievals remained low. Strategies to increase timely retrieval are needed, as nonretrieved IVCFs may have long-term complications.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.